Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 4/20 | 0.44 |
| ▸ | RAB9A | P51151 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.41 |
| ▸ | TNKS | O95271 | 2/20 | 0.41 |
| ▸ | TNKS2 | Q9H2K2 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.38 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.38 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.38 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL45841 | 0.90 | GPR3 (0.48) | GPR3MAPTRAB9AALDH1A1HPGD | |
| SCHEMBL19109079 | 0.87 | GPR3 (0.50) | GPR3MAPTRAB9AALDH1A1HPGD | |
| SCHEMBL22011414 | 0.86 | GPR3 (0.48) | GPR3MAPTRAB9AALDH1A1HPGD | |
| SCHEMBL22155783 | 0.85 | MAPT (0.45) | GPR3MAPTRAB9AALDH1A1HPGD | |
| SCHEMBL24039904 | 0.84 | GPR3 (0.56) | GPR3MAPTRAB9AALDH1A1HPGD | |
| SCHEMBL1294342 | 0.84 | GPR3 (0.56) | GPR3MAPTRAB9AALDH1A1HPGD | |
| SCHEMBL22155788 | 0.84 | GPR3 (0.42) | GPR3MAPTRAB9AALDH1A1HPGD | |
| SCHEMBL23819654 | 0.84 | GPR3 (0.42) | GPR3MAPTRAB9AALDH1A1HPGD | |
| SCHEMBL29709992 | 0.84 | ALOX5 (0.48) | GPR3MAPTRAB9AALDH1A1HPGD | |
| SCHEMBL24889877 | 0.84 | CYP1A2 (0.42) | GPR3MAPTRAB9AALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10003031-B2 | Compound for organic electric element, organic electric element comprising the same and electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2018-06-19 | — | — | US | disclosed |
| US-10003031-B2 | Compound for organic electric element, organic electric element comprising the same and electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2018-06-19 | — | — | US | disclosed |
| US-20150349276-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2015-12-03 | — | — | US | disclosed |
| US-20150349276-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2015-12-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150349276-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF | ORAI2, ESR1, OR10J3 | GPR3 4813/4885MAPT 1256/4885RAB9A 3586/4885 |
| US-10003031-B2 | Compound for organic electric element, organic electric element comprising the same and electronic device thereof | ORAI2, ESR1, OR10J3 | GPR3 4813/4885MAPT 1256/4885RAB9A 3586/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.